Juva Life Inc

CNSX:JUVA

Juva Life, Inc. engages in the cultivation, manufacturing, research and development, distribution and retail of medical and recreational cannabis. The company is headquartered in Vancouver, British Columbia and currently employs 24 full-time employees. The company went IPO on 2020-10-21. The firm operates in the medical and recreational cannabis sectors. The firm acquires, owns, and operates cannabis business in California. The firm is focused on the research, development, and commercialization of Cannabis products. Its initial pre-clinical discovery is Juva-019, is a non-cannabinoid purified small molecule isolated from Cannabis with broad spectrum anti-inflammatory properties. Juva-019 is a potent modulator of TNF-alpha, IL-1 beta, and several other clinically relevant cytokines. The firm has developed a chemical library of natural and semi-synthetic non-cannabinoids and is evaluating their therapeutic benefit alone and in combination across panels of industry-standard phenotypic and target-based anti-inflammatory assays.